Baxalta (United States)

Baxalta (United States)

Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

53%


Total
Publications

285


Total Open
Publications

152


Total
Citations

4.8K


Open Access
Percentage

53%


Total
Publications

285


Total Open
Publications

152


Total
Citations

4.8K

Wikipedia

Website

download

Breakdown

32% 18% 3% 47%

Publisher Open

32%

Both

18%

Other Platform Open

3%

Closed

47%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

11%OA Journal

OA Journal 11%

16

Hybrid 57%

82

No Guarantees 32%

46

Other Platform Open

Domain 85%

51

Institution 27%

16

Other Internet 12%

7

Preprint 3%

2

Public 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
51
Europe PMC
Domain
30
University of California - eScholarship University of California
Institution
7
California Digital Library - eScholarship
Other Internet
5
Cardiff University - ORCA Online Research @Cardiff
Institution
4
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
University of Bristol - Bristol Research
Institution
2
whiterose.ac.uk OAI-PMH Repository
Institution
1
University of Toronto - TSpace
Institution
1
University of Southampton - ePrints Soton
Institution
1
1 / 2

Data updated 17 June 2024

Share

Share

Share